SEARCH

SEARCH BY CITATION

References

  • 1
    Spits, H. and Di Santo, J. P., The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011. 12: 2127.
  • 2
    Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M. et al., Innate or adaptive immunity? The example of natural killer cells. Science 2011. 331: 4449.
  • 3
    Gascoyne, D. M., Long, E., Veiga-Fernandes, H., de Boer, J., Williams, O., Seddon, B., Coles, M. et al., The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 2009. 10: 11181124.
  • 4
    Kamizono, S., Duncan, G. S., Seidel, M. G., Morimoto, A., Hamada, K., Grosveld, G., Akashi, K. et al., Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 2009. 206: 29772986.
  • 5
    Spits, H. and Cupedo, T., Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 2012. 30: 647675.
  • 6
    van de Pavert, S. A. and Mebius, R. E., New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 2010. 10: 664674.
  • 7
    Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, II, Littman, D. R., Maloy, K. J. and Powrie, F., Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010. 464: 13711375.
  • 8
    Satoh-Takayama, N., Vosshenrich, C. A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J. J. et al., Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008. 29: 958970.
  • 9
    Takatori, H., Kanno, Y., Watford, W. T., Tato, C. M., Weiss, G., Ivanov, II, Littman, D. R. et al., Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009. 206: 3541.
  • 10
    Fallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A., Hewett, D. R., McIlgorm, A. et al., Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 2006. 203: 11051116.
  • 11
    Hurst, S. D., Muchamuel, T., Gorman, D. M., Gilbert, J. M., Clifford, T., Kwan, S., Menon, S. et al., New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 2002. 169: 443453.
  • 12
    Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K., Bucks, C. et al., Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010. 464: 13671370.
  • 13
    Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J. et al., Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010. 463: 540544.
  • 14
    Price, A. E., Liang, H. E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J. and Locksley, R. M., Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 2010. 107: 1148911494.
  • 15
    Brickshawana, A., Shapiro, V. S., Kita, H. and Pease, L. R., Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J. Immunol. 2011. 187: 57955804.
  • 16
    Wong, S. H., Walker, J. A., Jolin, H. E., Drynan, L. F., Hams, E., Camelo, A., Barlow, J. L. et al., Transcription factor RORalpha is critical for nuocyte development. Nat. Immunol. 2012. 13: 229236.
  • 17
    Kim, H. Y., DeKruyff, R. H. and Umetsu, D. T., The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat. Immunol. 2010. 11: 577584.
  • 18
    Voehringer, D., Reese, T. A., Huang, X., Shinkai, K. and Locksley, R. M., Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J. Exp. Med. 2006. 203: 14351446.
  • 19
    Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N., Donaldson, D. D., DeKruyff, R. H. and Umetsu, D. T., Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 2001. 167: 46684675.
  • 20
    Cohn, L., Tepper, J. S. and Bottomly, K., IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 1998. 161: 38133816.
  • 21
    Oliphant, C. J., Barlow, J. L. and McKenzie, A. N., Insights into the initiation of type 2 immune responses. Immunology 2011. 134: 378385.
  • 22
    Kondo, Y., Yoshimoto, T., Yasuda, K., Futatsugi-Yumikura, S., Morimoto, M., Hayashi, N., Hoshino, T. et al., Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 2008. 20: 791800.
  • 23
    Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N. and Kita, H., IL-33-responsive lineage-CD25+CD44hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 2012. 188: 15031513.
  • 24
    Kim, H. Y., Chang, Y. J., Subramanian, S., Lee, H. H., Albacker, L. A., Matangkasombut, P., Savage, P. B. et al., Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Allergy Clin. Immunol. 2012. 129: 216227, e216.
  • 25
    Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G., Doering, T. A., Angelosanto, J. M. et al., Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011. 12: 10451054.
  • 26
    Barlow, J. L., Bellosi, A., Hardman, C. S., Drynan, L. F., Wong, S. H., Cruickshank, J. P. and McKenzie, A. N., Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 2012. 129: 191198, e194.
  • 27
    Fallon, P. G., Emson, C. L., Smith, P. and McKenzie, A. N., IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J. Immunol. 2001. 166: 27122716.
  • 28
    Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y. and Elias, J. A., Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest 1999. 103: 779788.
  • 29
    Terashima, A., Watarai, H., Inoue, S., Sekine, E., Nakagawa, R., Hase, K., Iwamura, C. et al., A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 2008. 205: 27272733.
  • 30
    Jaradat, M., Stapleton, C., Tilley, S. L., Dixon, D., Erikson, C. J., McCaskill, J. G., Kang, H. S. et al., Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation. Am. J. Respir. Crit. Care Med. 2006. 174: 12991309.
  • 31
    Ikutani, M., Yanagibashi, T., Ogasawara, M., Tsuneyama, K., Yamamoto, S., Hattori, Y., Kouro, T. et al., Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J. Immunol. 2012. 188: 703713.
  • 32
    Wilhelm, C., Hirota, K., Stieglitz, B., Van Snick, J., Tolaini, M., Lahl, K., Sparwasser, T. et al., An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 2011. 12: 10711077.
  • 33
    Wilson, M. S. and Wynn, T. A., Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal. Immunol. 2009. 2: 103121.
  • 34
    Bartlett, N. W., Walton, R. P., Edwards, M. R., Aniscenko, J., Caramori, G., Zhu, J., Glanville, N. et al., Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 2008. 14: 199204.
  • 35
    Chang, Y. J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N., Smith, D. E., Dekruyff, R. H. et al., Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 2011. 12: 631638.
  • 36
    Guo, H. and Topham, D. J., Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection. J. Virol. 2010. 84: 77507759.
  • 37
    Stapleton, C. M., Jaradat, M., Dixon, D., Kang, H. S., Kim, S. C., Liao, G., Carey, M. A. et al., Enhanced susceptibility of staggerer (RORalphasg/sg) mice to lipopolysaccharide-induced lung inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 2005. 289: L144L152.
  • 38
    Mjosberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J.et al.,Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 2011. 12: 10551062.
  • 39
    Gudbjartsson, D. F., Bjornsdottir, U. S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G. M., Thorleifsson, G.et al., Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 2009. 41: 342347.
  • 40
    Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E. et al., A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 2010. 363: 12111221.
  • 41
    Prefontaine, D., Nadigel, J., Chouiali, F., Audusseau, S., Semlali, A., Chakir, J., Martin, J. G. et al., Increased IL-33 expression by epithelial cells in bronchial asthma. J. Allergy Clin. Immunol. 2010. 125: 752754.
  • 42
    Taube, C., Tertilt, C., Gyulveszi, G., Dehzad, N., Kreymborg, K., Schneeweiss, K., Michel, E.et al., IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One 2011. 6: e21799.
  • 43
    Zenewicz, L. A. and Flavell, R. A., Recent advances in IL-22 biology. Int. Immunol. 2011. 23: 159163.
  • 44
    Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F.et al., Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 2006. 203: 27152725.
  • 45
    Schnyder, B., Lima, C. and Schnyder-Candrian, S., Interleukin-22 is a negative regulator of the allergic response. Cytokine 2010. 50: 220227.
  • 46
    Besnard, A. G., Sabat, R., Dumoutier, L., Renauld, J. C., Willart, M., Lambrecht, B., Teixeira, M. M. et al., Dual role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am. J. Respir. Crit. Care Med. 2011. 183: 11531163.
  • 47
    Takahashi, K., Hirose, K., Kawashima, S., Niwa, Y., Wakashin, H., Iwata, A., Tokoyoda, K.et al.,IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J. Allergy Clin. Immunol. 2011. 128: 10671076, e1061–e1066.
  • 48
    Barlow, J. L., Flynn, R. J., Ballantyne, S. J.andMcKenzie, A. N., Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity. Clin. Exp. Allergy 2011. 41: 14471455.
  • 49
    Ballantyne, S. J., Barlow, J. L., Jolin, H. E., Nath, P., Williams, A. S., Chung, K. F., Sturton, G.et al.,Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J. Allergy Clin. Immunol. 2007. 120: 13241331.